Diagnosing Healthcare Stocks - Context

by Equities, AllianceBernstein

Transcript:

Healthcare feels like a mess today, doesnā€™t it? Thereā€™s been a tremendous amount of price inflation but very little price transparency. People donā€™t know what drugs cost. They donā€™t know what procedures cost. And we think that needs to change.

So we think the companies that are best positioned are those that can manage the tension between innovating and reducing costs for the overall system. And we think they exist; you just have to work really hard to find them.

We donā€™t believe you can consistently predict scientific outcomes and deliver a repeatable investment process over the long term, so we focus on the business. And as it relates to the business, we care a lot about return on invested capital. Most investors care about EPS growth, and we think those sorts of metrics are easily manufactured and manipulated. But ROIC really tells the true story about the value a company creates for its shareholders, and when you look at healthcare through that lens, there are lots of interesting companies in the medical device space, in the healthcare IT space and even in the drug development space.

We think that there are a couple of sectors that present some challenges. The first is the hospital sector, because thereā€™s no price transparency, and we think ultimately procedures will end up leaving the hospital as technologies improve and patients can get their procedures done in the same day in outpatient centers. We think drug distributors present some challenges. Their pricing model is different than a typical distributor such as UPS or FedEx. They charge based on how long theyā€™re taking the package and how much the package weighs. A drug distributor charges based on the value, and thatā€™s different and doesnā€™t make a lot of sense to us. Lastly, we think that there are some areas in the drug sector that are also challenged, and those are the companies that have taken egregious price increases for older drugs and havenā€™t innovated, and it doesnā€™t make a lot of sense. You wouldnā€™t pay more for an older iPhone, right?

Copyright Ā© AllianceBernstein

Total
0
Shares
Previous Article

This Self-Made Billionaire Reminds Americans that Only Capitalism Creates Wealth

Next Article

ULTA SALON COSMETICS & FRAGRANCE (ULTA) NASDAQ - Sep 10, 2018

Related Posts
Subscribe to AdvisorAnalyst.com notifications
Watch. Listen. Read. Raise your average.